BERLIN - Pfizer and BioNTech have submitted their Covid-19 vaccine to the European Medicines Agency for conditional approval, the companies said in a statement on Tuesday, aiming to make their drug available in Europe by the end of the year.
The partners - a US pharma giant and a small German biotechnology firm specializing in nascent mRNA technology - said receipt of their application had been confirmed after it was submitted on Monday.
This puts the companies neck and neck with US firm Moderna, which also applied to the EU regulator for the conditiona...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our SUBSCRIPTION